Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind study of SYHX2011 versus albumin-bound paclitaxel (克艾力) in advanced breast cancer
CTR20230660Phase 3Active
- Sponsor
- CSPC Ouyi Pharmaceutical
- Start
- Apr 2023
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of SYHX-2011 in breast cancer, sponsored by CSPC Ouyi Pharmaceutical. Started Apr 2023; status: active.
02
Drugs
SYHX-2011
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20230660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230660.